Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c02228
Abstract: Histone methyltransferase DOT1L is an attractive therapeutic target for the treatment of hematological malignancies. Here, we report the design, synthesis, and profiling of new DOT1L inhibitors based on nonroutine carbocyclic C-nucleoside scaffolds. The experimentally observed…
read more here.
Keywords:
inhibitors methyltransferase;
profiling highly;
selective inhibitors;
methyltransferase dot1l ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-17-0018
Abstract: Checkpoint-mediated dependency of tumor cells can be deployed to selectively kill them without substantial toxicity to normal cells. Specifically, loss of CHK1, a serine threonine kinase involved in the surveillance of the G2–M checkpoint in…
read more here.
Keywords:
dealkylation;
chk1;
synthesis profiling;
unusual trifluoromethylpyrazole ... See more keywords